Unlocking Cross-Border Growth: Modern Go-to-Market Strategies in Trade Finance
click here to discover importer exporter profiles & logistic partners
Shipments
Trading Partners
Markets
Products/HS Code
Exports Data of
maxence pharma
f-32, first floor f-32 sheikh sarai, phase-1 contact no: 918882529304, india
maxence pharma is based out of india with 15 export shipments recorded in global import export data.
Trade Trends of maxence pharma
from Jan 2022 to Sept 2025Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 15
As Supplier Trade Value (USD): $80.9 K
Import and Export shipments of "maxence pharma"
As Supplier
| Consignee Name | Shipper Name | HS Code | Shipment Weight (kg) | Product Keywords | Shipment Date |
|---|---|---|---|---|---|
| 300242 | 153 | NOBIVAK DHPPI IN THE FORM OF A LYOPHILIZATE FOR THE PREPARATION OF SUSPENSION FOR INJECTIONS DOSAGE: 0.5 ML. 1 DOSE) VACCINE AGAINST CANINE PLAGUE INFECTIOUS HEPATITIS PARVOVIRUS ENTERITIS AND PARAINFLUE OF DOGS LIVE DRY. - EXPIRY DATE 0624 TO 0626 | Jun 13, 2025 | ||
tm pharma llp | maxence pharma | 300242 | 153 | NOBIVAK DHPPI IN THE FORM OF A LYOPHILIZATE FOR THE PREPARATION OF SUSPENSION FOR INJECTIONS DOSAGE: 0.5 ML. 1 DOSE) VACCINE AGAINST CANINE PLAGUE INFECTIOUS HEPATITIS PARVOVIRUS ENTERITIS AND PARAINFLUE OF DOGS LIVE DRY. - EXPIRY DATE 0624 TO 0626 | Jun 13, 2025 |
tm pharma llp | maxence pharma | 300242 | 153 | NOBIVAK DHPPI IN THE FORM OF A LYOPHILIZATE FOR THE PREPARATION OF SUSPENSION FOR INJECTIONS DOSAGE: 0.5 ML. 1 DOSE) VACCINE AGAINST CANINE PLAGUE INFECTIOUS HEPATITIS PARVOVIRUS ENTERITIS AND PARAINFLUE OF DOGS LIVE DRY. - EXPIRY DATE 0624 TO 0626 | Jun 13, 2025 |
tm pharma llp | maxence pharma | 300242 | 153 | NOBIVAK DHPPI IN THE FORM OF A LYOPHILIZATE FOR THE PREPARATION OF SUSPENSION FOR INJECTIONS DOSAGE: 0.5 ML. 1 DOSE) VACCINE AGAINST CANINE PLAGUE INFECTIOUS HEPATITIS PARVOVIRUS ENTERITIS AND PARAINFLUE OF DOGS LIVE DRY. - EXPIRY DATE 0624 TO 0626 | Jun 13, 2025 |
tm pharma llp | maxence pharma | 300242 | 153 | NOBIVAK DHPPI IN THE FORM OF A LYOPHILIZATE FOR THE PREPARATION OF SUSPENSION FOR INJECTIONS DOSAGE: 0.5 ML. 1 DOSE) VACCINE AGAINST CANINE PLAGUE INFECTIOUS HEPATITIS PARVOVIRUS ENTERITIS AND PARAINFLUE OF DOGS LIVE DRY. - EXPIRY DATE 0624 TO 0626 | Jun 13, 2025 |
Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.
Solutions Built for Every Stage of Global Trade
Global Trade Management
Discover end-to-end compliance automation across classification, screening, and duties.
Know more
Intel
Discover high-potential prospects, qualify opportunities, and grow your pipeline.
Know more
SourceAtlas
Discover suppliers, compare sourcing markets, and make smarter sourcing decisions.
Know more
Trading Partners of maxence pharma
Top Companies "maxence pharma" is exporting to (by Value USD)
| Buyer | 2025 |
|---|---|
tm pharma llp | 67.57 K |
too simurg vita | 13.34 K |
Markets in which maxence pharma trades
Top Countries "maxence pharma" is exporting to (by Value USD)
| Importing Country | 2025 |
|---|---|
 kazakhstan | 80.9 K |
Products/HS Codes traded by maxence pharma
Top HS Codes Exported by "maxence pharma"
USD 75.61 K | 86.67%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- - Vaccines for veterinary medicine
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- - Vaccines for veterinary medicine
USD 5.3 K | 13.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Similar Companies to maxence pharma
Companies exporting similar HS Codes as of "maxence pharma" in india
Other Buyers and Suppliers in india who deal in similar products like maxence pharma
Explore Transformation Stories
How a US Freight Forwarder Generated
4x More Leads at $1 Cost Per Lead
Trademo’s global trade intelligence platform has allowed us to find leads easily, boosting the team’s productivity and making the process simpler.
Iliana Rodriguez
Operations Team Leader
Frequently Asked Questions
Who are the top buyers purchasing from Maxence Pharma?
According to trade records, some of the top buyers of Maxence Pharma include Tm Pharma Llp And Too Simurg Vita.
Which countries does Maxence Pharma trade with?
Customs data shows that Maxence Pharma is most active in trade with countries such as Kazakhstan.
How many shipments has Maxence Pharma in last 12 months?
In last 12 months, Maxence Pharma has been linked to 15 verified shipments tracked through international trade data.
What is the total export value of Maxence Pharma in last 12 months?
The total recorded export value of Maxence Pharma is estimated at $80.9 K till date, based on aggregated global shipment sources.
How can I analyze Maxence Pharma global trade network?
With Trademo, you can explore Maxence Pharma complete trade ecosystem including buyers, manufacturers, shipment volumes, and trade routes, helping you identify opportunities and risks.
APIs
Data License
Plans
Directories
Company
Location
United States
3000 El Camino Real, Building 4, Suite 200, Palo Alto, California 94306
India
2nd Floor, Plot No. 136, Sector 44, Gurugram, Haryana 122003
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.